Michael Christian Dobelbower MD
Professor, Radiation Oncology, University of Alabama School of Medicine
Join to View Full Profile
2145 Bonner WayBirmingham, AL 35243
Phone+1 205-934-9999
Fax+1 205-978-8310
Dr. Dobelbower is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Dobelbower is a radiation oncologist based in Birmingham, AL. He completed his residency in Radiation Oncology at the University of Alabama Medical Center and an internship at Mercy St Vincent Medical Center. He graduated from The University of Toledo College of Medicine in 2002. Dr. Dobelbower has experience in prostate cancer and has contributed to several publications, including research on intensity-modulated radiotherapy and stereotactic body radiation therapy. He has been involved in clinical trials focusing on prostate cancer and brain metastases. His work has garnered citations, and he received the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services in 2012.
Education & Training
University of Alabama Medical CenterResidency, Radiation Oncology, 2003 - 2007
Mercy St Vincent Medical Center/Mercy Health PartnersInternship, Transitional Year, 2002 - 2003
The University of Toledo College of MedicineClass of 2002
Certifications & Licensure
FL State Medical License 2023 - Present
AL State Medical License 2003 - 2025
OH State Medical License 2002 - 2003
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002) Start of enrollment: 2010 Oct 01
- Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
- Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203) Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 6 citationsExternal Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial.Ashley E Ross, Jingbin Zhang, Huei-Chung Huang, Rikiya Yamashita, Jessica Keim-Malpass
European Urology Oncology. 2024-10-01 - 3 citationsLong-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical Trial.Stephen G Chun, Chen Hu, Ritsuko U Komaki, Robert D Timmerman, Steven E Schild
JAMA Oncology. 2024-08-01 - 36 citationsA roadmap for implementation of kV-CBCT online adaptive radiation therapy and initial first year experiences.Dennis N Stanley, Joseph Harms, Joel A Pogue, Jean-Guy Belliveau, Samuel R Marcrom
Journal of Applied Clinical Medical Physics. 2023-07-01
Authored Content
- Stereotactic Radiosurgery for Prostate Cancer Following Magnetic Resonance Imaging Directed Biopsy: A Multidisciplinary Approach with Case ExamplesApril 2018
- Stereotactic Radiosurgery for Prostate Cancer Following Magnetic Resonance Imaging Directed Biopsy: A Multidisciplinary Approach with Case ExamplesApril 2018
Press Mentions
Team of UAB Doctors Performs New Procedure for Rare GI MelanomaMarch 30th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
